These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10190387)

  • 21. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.
    McIlleron H; Meintjes G; Burman WJ; Maartens G
    J Infect Dis; 2007 Aug; 196 Suppl 1():S63-75. PubMed ID: 17624828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the HIV-protease in AIDS therapy: a current clinical perspective.
    Tomasselli AG; Heinrikson RL
    Biochim Biophys Acta; 2000 Mar; 1477(1-2):189-214. PubMed ID: 10708858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute respiratory failure associated with the human immunodeficiency virus (HIV) protease inhibitor indinavir in an HIV-infected patient.
    Dieleman JP; in 't Veld B; Borleffs JC; Schreij G
    Clin Infect Dis; 1998 Apr; 26(4):1012-3. PubMed ID: 9564505
    [No Abstract]   [Full Text] [Related]  

  • 24. Utility of tuberculosis directly observed therapy programs as sites for access to and provision of antiretroviral therapy in resource-limited countries.
    Friedland G; Abdool Karim S; Abdool Karim Q; Lalloo U; Jack C; Gandhi N; El Sadr W
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S421-8. PubMed ID: 15156433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ritonavir and indinavir one year later.
    TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection.
    Hoffmann F; Funk M; Linde R; Notheis G; Petropoulou T; Eberle J; Gürtler L; Belohradsky BH; Wintergerst U
    Eur J Med Res; 2002 Jul; 7(7):330-4. PubMed ID: 12176683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of HIV infections and AIDS with protease inhibitor and two nucleoside analogs].
    Jensen-Fangel S; Larsen L; Thomsen HF; Nielsen LP; Black FT; Obel N
    Ugeskr Laeger; 1999 Mar; 161(12):1751-4. PubMed ID: 10210974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maintenance of successful ritonavir-boosted indinavir and efavirenz therapy in an HIV-infected patient with tuberculosis.
    Boyd MA; Burger DM; Phanuphak P; Cooper DA
    AIDS; 2006 Apr; 20(7):1083-5. PubMed ID: 16603870
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary stones in HIV-1-positive patients treated with indinavir.
    Daudon M; Estépa L; Viard JP; Joly D; Jungers P
    Lancet; 1997 May; 349(9061):1294-5. PubMed ID: 9142068
    [No Abstract]   [Full Text] [Related]  

  • 30. Severe hepatitis in three AIDS patients treated with indinavir.
    Bräu N; Leaf HL; Wieczorek RL; Margolis DM
    Lancet; 1997 Mar; 349(9056):924-5. PubMed ID: 9093260
    [No Abstract]   [Full Text] [Related]  

  • 31. Issues in the treatment of active tuberculosis in human immunodeficiency virus-infected patients.
    Schluger NW
    Clin Infect Dis; 1999 Jan; 28(1):130-5. PubMed ID: 10028083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome.
    Clarke SM; Mulcahy F; Healy CM; Condon S; Butler KM
    Int J STD AIDS; 2000 Apr; 11(4):220-3. PubMed ID: 10772084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of mycobacterial infections in patients with HIV/AIDS].
    Pulido F; Iribarren JA; Kindelan JM; Moreno S
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():20-8. PubMed ID: 9859616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical application of HIV protease inhibitors].
    Chiba N; Shintani M; Ueno T; Hayashi H
    Tanpakushitsu Kakusan Koso; 1998 May; 43(6):744-51. PubMed ID: 9612068
    [No Abstract]   [Full Text] [Related]  

  • 35. Tuberculosis in non-Haitian patients with acquired immunodeficiency syndrome.
    Louie E; Rice LB; Holzman RS
    Chest; 1986 Oct; 90(4):542-5. PubMed ID: 3757564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir.
    Matsuda J; Gohchi K
    Lancet; 1997 Aug; 350(9074):364. PubMed ID: 9251655
    [No Abstract]   [Full Text] [Related]  

  • 37. Fatal acute haemolysis in an AIDS patient treated with indinavir.
    Prazuck T; Semaille C; Roques S
    AIDS; 1998 Mar; 12(5):531-3. PubMed ID: 9543454
    [No Abstract]   [Full Text] [Related]  

  • 38. Profile of HIV associated tuberculosis at a tertiary institute in setting of free anti-retroviral therapy.
    Agarwal U; Kumar A; Behera D
    J Assoc Physicians India; 2009 Oct; 57():685-90. PubMed ID: 20329424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis and HIV co-infection: a practical therapeutic approach.
    Breen RA; Swaden L; Ballinger J; Lipman MC
    Drugs; 2006; 66(18):2299-308. PubMed ID: 17181373
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tuberculosis therapy 1990].
    Villiger B
    Schweiz Rundsch Med Prax; 1990 May; 79(21):670-4. PubMed ID: 2190295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.